Jeffrey W. Albers Blueprint Medicines Corp (BPMC) insider trading activity
Jeffrey W. Albers is of Blueprint Medicines Corp. Currently has a direct ownership of 157,557 shares of BPMC, which is worth approximately $14 Million. The most recent transaction as insider was on Nov 15, 2021, when has been sold 30,000 shares (Common Stock) at a price of $8.44 per share, resulting in proceeds of $253,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
158K
5.8%
3M change
10.5%
12M change
Total Value Held
$14 Million
Jeffrey W. Albers Transaction History
Also insider at
JWA
Jeffrey W. Albers
Cambridge, MA